Submission to the 2015 Spending Review

The Academy responds to a call from the Treasury for evidence to inform the 2015 Spending Review.

Status: Ongoing

Evidence about medicines: our engagement with stakeholders

As part of our workstream on ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’, the Academy engaged widely with a range of stakeholders.

Status: Completed

Communicating evidence about medicines

As part of our workstream on ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’, the Academy held two events on the topic of ‘Communicating evidence about medicines’.

Status:

Conflicts of interest workshop

On 27 November 2015, the Academy held a workshop on ‘Conflicts of interest’ as part of its wider workstream on ‘Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines’.

Status: Completed

Accelerated Access Review

Status: Completed

Multiple morbidities as a global health challenge

Status: Completed

Consultation on Tier 2 immigration visas

Status: Ongoing

Science Advice in Europe

The Academy promotes the value of science advice in the EU

Status: Completed

Psychoactive Substances Bill

In 2015, the Academy and other medical and research bodies worked with the Home Office to try and mitigate any potential unintended consequences of the Psychoactive Substances Bill on medical research.

Status:

Sources of evidence for assessing the safety, efficacy and effectiveness of medicines

The Academy of Medical Sciences published a working group report examining the sources of evidence for assessing the safety, efficacy and effectiveness of medicines. 

Status: Completed